Funding · Company
Aviceda Therapeutics, Inc.
Cambridge, MABiotech & Pharma
Aviceda Therapeutics, Inc. of Cambridge, MA has disclosed $124M across 2 Form D offerings filed with the SEC between Mar 28, 2022 and Jan 13, 2025.
$124M
Total disclosed
2
Form D offerings
This CIK has filed under more than one name: Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc.. We use the most recent.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$75M
Form D · Jan 13, 2025 ↗
Q1 2025
· 1 amendment, first filed Nov 22, 2024
· target $207M
$49M
Form D · Mar 28, 2022 ↗
Q1 2022
· target $80M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001824762Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →